Grant Life Sciences

Grant Life Sciences was a biotechnology company focused on developing and marketing diagnostic tests for infectious diseases and cancer, with a primary emphasis on Human Papillomavirus (HPV) and cervical cancer. The company aimed to provide affordable, high-throughput molecular diagnostic kits, specifically targeting underserved markets in Asia and other developing regions. Its lead product was an HPV DNA test designed to identify high-risk strains associated with the development of cervical malignancies. The company also explored diagnostic solutions for other conditions, including HIV and other sexually transmitted infections. Despite its early commercialization efforts and public listing, the company eventually became inactive and ceased operations.